The global fampridine market is expected to grow at a significant rate during the forecast (2024-2031). The key companies operating in the industry are highly inclined to adopt numerous growth strategies including partnerships collaborations, mergers and acquisitions, geographical expansion, and new product introductions to fulfill the growing market demands that is the key factor driving the market growth For instance, in December 2018, Hikma Pharmaceuticals USA Inc., formerly known as West-Ward Pharmaceuticals Corp., launched Dalfampridine Extended-release Tablets, 10 mg, the generic pharmaceutical equivalent to Ampyra, according to Hikma Pharmaceuticals PLC.
Get Free Sample link @ https://www.omrglobal.com/request-sample/fampridine-market
Apart from these, the significant approvals to drug developed by market players is further helping in the market growth. Such as, in May 2021, Bojian Company announced that Fampridine Sustained-Release Tablets had been approved by China’s National Medical Products Administration for the treatment of multiple sclerosis (MS) in adult patients with a walking disorder. Fampridine sustained-release pills are the first medication in China to improve the walking capacity of adult MS patients. Fampridine sustained-release pills are among the first batch of clinically urgently needed international new medications. The findings revealed that patients who were given fampridine sustained-release pills walked much faster than those who were given a placebo.
Full report of Fampridine Market available @ https://www.omrglobal.com/industry-reports/fampridine-market
Market Coverage
Segment Covered-
- By type
- By form
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape- including Tiefenbacher, Clearsynth, Jubilant Pharma, Teva, Kunshan Zhendong Chemical and others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Fampridine Market Report Segment
By type
- Purity: 95%
- Purity: >95%
By form
- Branded
- Generic
Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/fampridine-market
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
